New Square Capital LLC Repligen Corp Transaction History

New Square Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	SELL	$138.42 - $180.31 $69,348 - $90,335	-501 Reduced 98.82%	6 $0
Q4 2022 Feb 06, 2023	BUY	$162.42 - $220.56 $324 - $441	2 Added 0.4%	507 $85,000
Q2 2022 Jul 26, 2022	BUY	$140.68 - $188.02 $70,340 - $94,010	500 Added 10000.0%	505 $82,000
Q1 2022 May 10, 2022	SELL	$161.19 - $257.96 $161 - $257	-1 Reduced 16.67%	5 $1,000
Q1 2021 May 10, 2021	BUY	$180.37 - $226.26 $1,082 - $1,357	6 New	6 $1,000
Q1 2020 May 08, 2020	SELL	$84.96 - $109.14 $588,348 - $755,794	-6,925 Closed	0 $0
Q4 2019 Jan 10, 2020	BUY	$73.84 - $93.08 $511,342 - $644,579	6,925 New	6,925 $641,000

489

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.91B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of New Square Capital LLC, based on Form 13F filings with the SEC.

Stay updated on New Square Capital LLC with notifications on news.